Bank of Ann Arbor’s AbbVie ABBV Stock Holding History

Bank of Ann Arbor’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.83M	Buy	+10,834	New	+$2.78M	0.4%	56

Other funds holding ABBV

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Bank of Ann Arbor's ABBV Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in AbbVie (ABBV) in Q3 2026: 10,834 shares worth $2.83M. The stake represents 0.4% of the portfolio and ranks #56 among its holdings.

3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Bank of Ann Arbor held 10,834 shares of AbbVie worth $2.83M as of Q3 2026.
AbbVie was a new Bank of Ann Arbor position in Q3 2026.
AbbVie made up 0.4% of Bank of Ann Arbor's portfolio in Q3 2026, its #56 holding.
3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.